Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia

被引：0
|
作者：
Siami, K [1 ]
Awagu, S [1 ]
Cooper, DG [1 ]
Thomas, DA [1 ]
Huh, Y [1 ]
Jones, D [1 ]
Chen, W [1 ]
Jorgensen, JL [1 ]
机构：
[1] UTMDACC, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1143
引用
收藏
页码：246A / 247A
页数：2
相关论文
共 50 条
  • [41] Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease
    van Wering, ER
    Van der Linden-Schrever, BEM
    Szczepanski, T
    Willemse, MJ
    Baars, EA
    Van Wijngaarde-Schmitz, HM
    Kamps, WA
    Van Dongen, JJM
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 139 - 146
  • [42] Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy
    Zhiyu Liu
    Yang Li
    Ce Shi
    International Journal of Hematology, 2021, 113 : 337 - 343
  • [43] Measurable residual disease in childhood B-cell acute lymphoblastic leukemia
    Gale, Robert Peter
    BLOOD SCIENCE, 2022, 4 (04): : 209 - 210
  • [44] Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country
    Patkar, Nikhil
    Abu Alex, Ansu
    Bargavi, B.
    Ahmed, Rayaz
    Abraham, Aby
    George, Biju
    Vishwabandya, Auro
    Srivastava, Alok
    Mathews, Vikram
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (04) : 252 - 258
  • [45] THE CONTRIBUTION OF CD49F TO THE FLOW CYTOMETRIC MINIMAL RESIDUAL DISEASE DETERMINATION IN PEDIATRIC B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Albayrak, C.
    Albayrak, D.
    LEUKEMIA RESEARCH, 2014, 38 : S43 - S43
  • [46] Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia
    Jo, Irene
    Chung, Nack-Gyun
    Lee, Seok
    Kwon, Ahlm
    Kim, Jiyeon
    Choi, Hayoung
    Jang, Woori
    Kim, Seongkoo
    Lee, Jae Wook
    Yoon, Jae-Ho
    Cho, Bin
    Han, Kyungja
    Kim, Yonggoo
    Kim, Myungshin
    CLINICA CHIMICA ACTA, 2019, 488 : 81 - 89
  • [47] Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia
    Demina, Irina
    Voropayev, Alexander
    Semchenkova, Alexandra
    Zerkalenkova, Elena
    Olshanskaya, Yulia
    Samochatova, Elena
    Novichkova, Galina
    Miakova, Natalia
    Maschan, Alexey
    Popov, Alexander
    LEUKEMIA RESEARCH, 2021, 100
  • [48] CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia
    Rhein, Peter
    Mitlohner, Rita
    Basso, Giuseppe
    Gaipa, Giuseppe
    Dworzak, Michael N.
    Kirschner-Schwabe, Renate
    Hagemeier, Christian
    Stanulla, Martin
    Schrappe, Martin
    Ludwig, Wolf-Dieter
    Karawajew, Leonid
    Ratei, Richard
    BLOOD, 2010, 115 (18) : 3763 - 3771
  • [49] Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000
    Schumich, Angela
    Maurer-Granofszky, Margarita
    Attarbaschi, Andishe
    Poetschger, Ulrike
    Buldini, Barbara
    Gaipa, Giuseppe
    Karawajew, Leonid
    Printz, Dieter
    Ratei, Richard
    Conter, Valentino
    Schrappe, Martin
    Mann, Georg
    Basso, Giuseppe
    Dworzak, Michael N.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
  • [50] Acute Lymphoblastic Leukemia Transformation with a Precursor B-Cell Immunophenotype to Burkitt's Lymphoma: a Case Report
    Jafari, Masoumeh
    Damavandi, Shahla Ansari
    Charmduzi, Forugh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 760 - 764
12345